🔎 Trials Near Me

Dachaigh › Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil › Connecticut

Sgrùdaidhean clionaigeach Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil ann an Connecticut

Tha 24 sgrùdaidhean airson Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil a’ lorg phàirtichean aig làraichean ann an Connecticut.

Bailtean ann an Connecticut

Teacsa sgrùdaidh oifigeil (Beurla)

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #62, New Haven
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05176483

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  • Smilow Cancer Hospital - Yale New Haven Health, New Haven
  • Yale - New Haven Hospital - Yale Cancer Center, New Haven
  • Smilow Cancer Hospital Phase 1 Unit, New Haven
  • agus 1 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07090499

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

  • Yale University - Yale University School of Medicine, New Haven
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07360314

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  • Hartford Hospital, Hartford
  • Yale Cancer Center, New Haven
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

  • Yale Cancer Center, New Haven
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06385080

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, New Have
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07229313

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • Yale University, New Haven
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04671667

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Yale University, Yale Cancer Center, New Haven
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05983432

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich
  • Smilow Cancer Hospital Care Center - Guilford, Guilford
  • Smilow Cancer Center/Yale-New Haven Hospital, New Haven
  • agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT02734537

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

  • Yale Cancer Center, New Haven
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06657222

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

  • Yale University Cancer Center, New Haven
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06597721

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, New Haven
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

  • Yale University, New Haven
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT04333537

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

  • Yale University, New Haven
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Iuch 2026 · NCT07172256

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

  • Yale Comprehensive Cancer Center, New Haven
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06747585

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • Yale University, Yale Cancer Center, New Haven
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT06993844

5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

  • Yale University, New Haven
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT05317000

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • Yale University School of Medicine /ID# 225707, New Haven
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT04777994

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

  • GSK Investigational Site, Farmington
  • GSK Investigational Site, New Haven
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT06256588

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Yale School of Medicine - Smilow Cancer Hospital, New Haven
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Gibl 2026 · NCT06064877

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • Hartford Hospital (site 210), Hartford
A’ fastadhÌre 1/2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Dùbh 2025 · NCT03556228

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

  • Yale Cancer Center, New Haven
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Samh 2025 · NCT05902988

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

  • Yale Cancer Center, New Haven
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Samh 2024 · NCT04787042

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

  • Yale, New Haven
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Màrt 2024 · NCT05280314

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.